Guardian Pharmacy Services, Inc.

GRDN Healthcare Medical Care Facilities

Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.

Revenue
−1.68%
EPS
+133.3%
Free cash flow
+88.9%

Quarter to September 2026, against a year earlier

39.72 2.37 −5.63%
Market cap
$2.5B
P/E
37.8×
Fwd P/E
33.3×
Dividend yield
—
F-score
7/9
Altman Z
10.28
Beneish M
−2.95
Dividend safety
n/a

Guardian Pharmacy Services, Inc. (GRDN) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Guardian Pharmacy Services, Inc. (GRDN) trades at a EV/Sales of 1.7×. Over the past ten years it has ranged from 0.0× (September 2024) to 2.0× (September 2026); the current reading is higher than 83% of that period. That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.3× 21.60%
FY2024 1.1× —
FY2023 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.7× (3.38%)
Jun 2026 1.8× 9.70%
Mar 2026 1.6× 26.82%
Dec 2025 1.3× 8.77%
8 more quarters

Against its own ten years

Low 0.0× High 2.0×
Ten-year median 1.3×
Current reading's percentile 83

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on GRDN